Histologic studies of the intraocular toxicity of imatinib mesylate in rabbits

A. S. Kitzmann, Keith Baratz, B. G. Mohney, Jose S Pulido, J. D. Cameron, E. S. Lee, Edward B Leof

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Purpose: To evaluate histologic signs of toxicity of the protein tyrosine kinase inhibitor, imatinib mesylate, in rabbit eyes. Methods: Twenty Dutch-belted rabbits underwent intravitreal injections of 0.1ml solutions of imatinib mesylate. Ten rabbits were killed and enucleated 1 week after injection of imatinib mesylate (1.65mg (four eyes), 165μg (four eyes), and 16.5μg (two eyes)). Ten rabbits injected with imatinib mesylate (165μg (five eyes) and 825μg (five eyes)) were enucleated 1 month later. Eyes were fixed in 10% formalin and stained with haematoxylin and eosin for microscopic examination. Results: All four eyes injected with 1.65 mg of imatinib mesylate and enucleated at 1 week demonstrated ocular toxicity. All four eyes injected with 165μg and enucleated at 1 week showed no ocular toxicity. One of the two eyes injected with 16.5μg and enucleated at 1 week revealed focal areas of subretinal fluid and retinal undulations, suggestive of retinal oedema. None of the 10 eyes injected with imatinib mesylate at either the 165 or 825μg dose and enucleated at 1 month showed ocular toxicity. Conclusions: Imatinib mesylate at 1.65 mg caused extensive retinal toxicity in rabbit eyes. In contrast, lower doses did not appear to cause toxicity, but may be associated with retinal oedema.

Original languageEnglish (US)
Pages (from-to)712-714
Number of pages3
JournalEye
Volume22
Issue number5
DOIs
StatePublished - May 2008

Fingerprint

Rabbits
Papilledema
Imatinib Mesylate
Subretinal Fluid
Intravitreal Injections
Hematoxylin
Protein Kinase Inhibitors
Eosine Yellowish-(YS)
Protein-Tyrosine Kinases
Formaldehyde
Injections

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Histologic studies of the intraocular toxicity of imatinib mesylate in rabbits. / Kitzmann, A. S.; Baratz, Keith; Mohney, B. G.; Pulido, Jose S; Cameron, J. D.; Lee, E. S.; Leof, Edward B.

In: Eye, Vol. 22, No. 5, 05.2008, p. 712-714.

Research output: Contribution to journalArticle

Kitzmann, A. S. ; Baratz, Keith ; Mohney, B. G. ; Pulido, Jose S ; Cameron, J. D. ; Lee, E. S. ; Leof, Edward B. / Histologic studies of the intraocular toxicity of imatinib mesylate in rabbits. In: Eye. 2008 ; Vol. 22, No. 5. pp. 712-714.
@article{42720ced317247118fc08f76c97fb64f,
title = "Histologic studies of the intraocular toxicity of imatinib mesylate in rabbits",
abstract = "Purpose: To evaluate histologic signs of toxicity of the protein tyrosine kinase inhibitor, imatinib mesylate, in rabbit eyes. Methods: Twenty Dutch-belted rabbits underwent intravitreal injections of 0.1ml solutions of imatinib mesylate. Ten rabbits were killed and enucleated 1 week after injection of imatinib mesylate (1.65mg (four eyes), 165μg (four eyes), and 16.5μg (two eyes)). Ten rabbits injected with imatinib mesylate (165μg (five eyes) and 825μg (five eyes)) were enucleated 1 month later. Eyes were fixed in 10{\%} formalin and stained with haematoxylin and eosin for microscopic examination. Results: All four eyes injected with 1.65 mg of imatinib mesylate and enucleated at 1 week demonstrated ocular toxicity. All four eyes injected with 165μg and enucleated at 1 week showed no ocular toxicity. One of the two eyes injected with 16.5μg and enucleated at 1 week revealed focal areas of subretinal fluid and retinal undulations, suggestive of retinal oedema. None of the 10 eyes injected with imatinib mesylate at either the 165 or 825μg dose and enucleated at 1 month showed ocular toxicity. Conclusions: Imatinib mesylate at 1.65 mg caused extensive retinal toxicity in rabbit eyes. In contrast, lower doses did not appear to cause toxicity, but may be associated with retinal oedema.",
author = "Kitzmann, {A. S.} and Keith Baratz and Mohney, {B. G.} and Pulido, {Jose S} and Cameron, {J. D.} and Lee, {E. S.} and Leof, {Edward B}",
year = "2008",
month = "5",
doi = "10.1038/sj.eye.6703092",
language = "English (US)",
volume = "22",
pages = "712--714",
journal = "Eye (Basingstoke)",
issn = "0950-222X",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Histologic studies of the intraocular toxicity of imatinib mesylate in rabbits

AU - Kitzmann, A. S.

AU - Baratz, Keith

AU - Mohney, B. G.

AU - Pulido, Jose S

AU - Cameron, J. D.

AU - Lee, E. S.

AU - Leof, Edward B

PY - 2008/5

Y1 - 2008/5

N2 - Purpose: To evaluate histologic signs of toxicity of the protein tyrosine kinase inhibitor, imatinib mesylate, in rabbit eyes. Methods: Twenty Dutch-belted rabbits underwent intravitreal injections of 0.1ml solutions of imatinib mesylate. Ten rabbits were killed and enucleated 1 week after injection of imatinib mesylate (1.65mg (four eyes), 165μg (four eyes), and 16.5μg (two eyes)). Ten rabbits injected with imatinib mesylate (165μg (five eyes) and 825μg (five eyes)) were enucleated 1 month later. Eyes were fixed in 10% formalin and stained with haematoxylin and eosin for microscopic examination. Results: All four eyes injected with 1.65 mg of imatinib mesylate and enucleated at 1 week demonstrated ocular toxicity. All four eyes injected with 165μg and enucleated at 1 week showed no ocular toxicity. One of the two eyes injected with 16.5μg and enucleated at 1 week revealed focal areas of subretinal fluid and retinal undulations, suggestive of retinal oedema. None of the 10 eyes injected with imatinib mesylate at either the 165 or 825μg dose and enucleated at 1 month showed ocular toxicity. Conclusions: Imatinib mesylate at 1.65 mg caused extensive retinal toxicity in rabbit eyes. In contrast, lower doses did not appear to cause toxicity, but may be associated with retinal oedema.

AB - Purpose: To evaluate histologic signs of toxicity of the protein tyrosine kinase inhibitor, imatinib mesylate, in rabbit eyes. Methods: Twenty Dutch-belted rabbits underwent intravitreal injections of 0.1ml solutions of imatinib mesylate. Ten rabbits were killed and enucleated 1 week after injection of imatinib mesylate (1.65mg (four eyes), 165μg (four eyes), and 16.5μg (two eyes)). Ten rabbits injected with imatinib mesylate (165μg (five eyes) and 825μg (five eyes)) were enucleated 1 month later. Eyes were fixed in 10% formalin and stained with haematoxylin and eosin for microscopic examination. Results: All four eyes injected with 1.65 mg of imatinib mesylate and enucleated at 1 week demonstrated ocular toxicity. All four eyes injected with 165μg and enucleated at 1 week showed no ocular toxicity. One of the two eyes injected with 16.5μg and enucleated at 1 week revealed focal areas of subretinal fluid and retinal undulations, suggestive of retinal oedema. None of the 10 eyes injected with imatinib mesylate at either the 165 or 825μg dose and enucleated at 1 month showed ocular toxicity. Conclusions: Imatinib mesylate at 1.65 mg caused extensive retinal toxicity in rabbit eyes. In contrast, lower doses did not appear to cause toxicity, but may be associated with retinal oedema.

UR - http://www.scopus.com/inward/record.url?scp=44049103691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44049103691&partnerID=8YFLogxK

U2 - 10.1038/sj.eye.6703092

DO - 10.1038/sj.eye.6703092

M3 - Article

C2 - 18239681

AN - SCOPUS:44049103691

VL - 22

SP - 712

EP - 714

JO - Eye (Basingstoke)

JF - Eye (Basingstoke)

SN - 0950-222X

IS - 5

ER -